Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

BVMF/B1SX34 stock hub

BVMF/B1SX34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BVMF/B1SX34is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
392.6B
Brazil Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
BVMF/B1SX34
In the news

Latest news · BVMF/B1SX34

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.5
P25 11.3P50 14.6P75 19.6
Trailing P/E21.1
P25 15.2P50 21.5P75 27.3
ROE14.7
P25 5.3P50 12.3P75 22.5
ROIC11.1
P25 7P50 12.5P75 22.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BVMF/B1SX34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
213
Groups with data
11
Currency
USD
Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
United States
Country code
BR
Employees
59,000
Employees Change
5,000%
Employees Change Percent
10.42
Enterprise value
BRL 440.7B
Exchange
Brazil Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Medical Devices
Last refreshed
2026-05-10
Market cap
BRL 392.6B
Price
BRL 263
Price currency
BRL
Rev Per Employee
1,822,670.66x
Sector
Healthcare
Sic
3845
Symbol
bvmf/B1SX34
Website
https://www.bostonscientific.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
4.74%
EV Earnings
23.69x
EV/EBIT
21.91x
EV/EBITDA
16.36x
EV/FCF
24.31x
EV/Sales
4.36x
FCF yield
4.62%
Forward P/E
15.5x
P/B ratio
2.88x
P/E ratio
21.11x
P/S ratio
3.65x
PE Ratio10 Y
88.45x
PE Ratio3 Y
60.97x
PE Ratio5 Y
69.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
19.92%
EBITDA Margin
26.68%
FCF margin
16.86%
Gross margin
68.94%
Gross Profit
BRL 74.1B
Gross Profit Growth
18.28%
Gross Profit Growth Q
12.67%
Gross Profit Growth3 Y
16.63%
Gross Profit Growth5 Y
15.5%
Net Income
BRL 18.6B
Net Income Growth
75.44%
Net Income Growth Q
98.96%
Net Income Growth3 Y
61.52%
Net Income Growth5 Y
77.73%
Pretax Margin
18.16%
Profit Margin
17.29%
Profit Per Employee
BRL 315,214
ROA
6.07
Roa5y
4.61
ROCE
10.32
ROE
14.66
Roe5y
8.1
ROIC
11.13
Roic5y
7.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

20
MetricValue
Cagr1y
-56.42%
Cagr3y
1.03%
Cagr5y
3.11%
EPS Growth
74.39
EPS Growth Q
100
EPS Growth3 Y
59.39
EPS Growth5 Y
76.04
FCF Growth
15.3%
FCF Growth Q
-51.7%
FCF Growth3 Y
42.69%
FCF Growth5 Y
18.01%
OCF Growth
13.88%
OCF Growth Q
-35.68%
OCF Growth10 Y
16.87%
OCF Growth3 Y
34.76%
OCF Growth5 Y
18.36%
Revenue Growth
17.43x
Revenue Growth Q
11.58x
Revenue Growth3 Y
16.48x
Revenue Growth5 Y
15.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
BRL 0.49
Assets
BRL 231.4B
Cash
BRL 7.6B
Current Assets
BRL 42.7B
Current Liabilities
BRL 22.5B
Debt
BRL 57.5B
Debt EBITDA
BRL 2.01
Debt Equity
BRL 0.42
Debt FCF
BRL 3.17
Equity
BRL 136.2B
Interest Coverage
11.5
Liabilities
BRL 95.2B
Long Term Assets
BRL 188.7B
Long Term Liabilities
BRL 72.7B
Net Cash
BRL -50B
Net Cash By Market Cap
BRL -12.72
Net Debt EBITDA
BRL 1.74
Net Debt Equity
BRL 0.37
Net Debt FCF
BRL 2.76
Tangible Book Value
BRL 1.4B
Tangible Book Value Per Share
BRL 0.94
WACC
7.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.9
Inventory Turnover
2.14
Net Working Capital
BRL 14.1B
Quick ratio
0.98
Working Capital
BRL 21.5B
Working Capital Turnover
BRL 33.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
-56.39%
200-day SMA
485
3Y total return
3.12%
50-day SMA
339.4
50-day SMA vs 200-day SMA
50under200
5Y total return
16.56%
All Time High
615.1
All Time High Change
-57.21%
All Time High Date
2025-02-10
All Time Low
134.5
All Time Low Change
95.75%
All Time Low Date
2020-03-18
ATR
9.71
Beta
0.62
Ch YTD
-50.19
High
263.2
High52
604.2
High52 Date
2025-07-23
High52ch
-56.44%
Low
263.2
Low52
263.2
Low52 Date
2026-05-08
Low52ch
0%
Ma50ch
-22.45%
Price vs 200-day SMA
-45.73%
RSI
29.41
RSI Monthly
27.44
RSI Weekly
20.51
Sharpe ratio
-2.17x
Sortino ratio
-2.42
Total Return
-0.42%
Tr YTD
-50.19
Tr1m
-17.26%
Tr1w
-7.03%
Tr3m
-33.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
BRL 21.4B
Operating Income Growth
26.49
Operating Income Growth Q
14.41
Operating Income Growth3 Y
24.38
Operating Income Growth5 Y
26.87
Operating margin
19.92

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
1,482,065,479%
Net Borrowing
-4,899,457,400
Shares Insiders
0.19%
Shares Institutions
91.73%
Shares Qo Q
-0.05%
Shares Yo Y
0.42%
Short Ratio
1.58

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

59
MetricValue
Adjusted FCF
BRL 16.5B
Average Volume
1,706.05x
Bv Per Share
90.78
CAPEX
BRL -4.5B
Ch1m
-17.26
Ch1w
-7.03
Ch1y
-56.39
Ch3m
-33.7
Ch3y
3.12
Ch5y
16.56
Ch6m
-50.57
Change
-6.23%
Change From Open
0
Close
280.7
Days Gap
-6.23
Depreciation Amortization
6,850,394,800
Dollar Volume
263.2
Earnings Date
2026-04-22
EBIT
BRL 21.4B
EBITDA
BRL 28.7B
EPS
BRL 12.47
F Score
7
FCF
BRL 18.1B
FCF EV Yield
4.11x
Financing CF
-4,632,451,800
Fiscal Year End
December
Founded
1,979
Goodwill
91,089,611,200
Graham Number
160.03761
Graham Upside
-39.2
Income Tax
BRL 959.9M
Investing CF
-14,246,875,975
Is Primary Listing
0
Last Earnings Date
2026-04-22
Last Report Date
2026-03-31
Lynch Fair Value
BRL 312
Lynch Upside
18.43
Ma150
455.5
Ma150ch
-42.22%
Ma20
301.4
Ma20ch
-12.66%
Net CF
3,776,908,900
Next Earnings Date
2026-07-29
Open
263.2
P FCF Ratio
21.66
P OCF Ratio
17.34
Ppne
22,654,462,000
Price Date
2026-05-08
Price EBITDA
BRL 13.68
Ptbv Ratio
280.8
Relative Volume
0x
Revenue
107,537,569,150x
SBC By Revenue
1.49x
Share Based Comp
1,606,751,300
Tax By Revenue
0.89x
Tax Rate
4.92%
Tr6m
-50.57%
Volume
1
Z Score
5.77
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BVMF/B1SX34 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/B1SX34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-56.4%
S&P 500 1Y: n/a
3Y total return
+3.1%
S&P 500 3Y: n/a
5Y total return
+16.6%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BVMF/B1SX34?

Insider, institutional, and short-interest positioning.

Institutional ownership
+91.7%
Share of float held by funds and institutions
Insider ownership
+0.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
1.6 days to cover
Y/Y dilution
+0.4%
Negative means the company is buying back shares.
Technical

BVMF/B1SX34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
29.4
Below 30: short-term oversold
Price vs 200-day MA
-45.7%
50/200-day relationship not available
Beta (5Y)
0.62
Less volatile than the market
Sharpe ratio
-2.17
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BVMF/B1SX34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/B1SX34 stock rating?

bvmf/B1SX34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/B1SX34 analysis?

The full report lives at /stocks/bvmf/B1SX34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/B1SX34?

The latest report frames bvmf/B1SX34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/B1SX34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

bvmf/B1SX34 stock profile: metrics, valuation and analysis | Agent IA du Marché Boursier